nfimpuls.cz

All DMD medicinal products primarily have an anti-inflammatory effect. Therefore, their ability to modify the natural course of the disease only concerns the initial stages of the disease.

The symptoms of the disease can be influenced in each stage of the disease if the symptoms are troubling the patient.

Participation of pathogenic antibodies in the pathogenic process of MS is assumed at least in some of the patients. Therefore, liquidation of the cells, which have the potential of maturing into cells creating antibodies (plasmacytes), is a logical method of treatment.